Gregory H. Jones, MD

  • 2Articles
  • 18.5KReads
  • 2022–2024Active
  • 13Collaborators
  • 12Citations

About

Gregory H. Jones, MD, is affiliated with the Department of Psychiatry and Behavioral Sciences at The University of Texas Health Science Center at Houston. His publications focus on bipolar disorder, major depressive disorder, schizophrenia and schizoaffective disorders, and issues affecting veterans and military populations. His work includes clinical trials investigating treatments such as intranasal ketamine for depression and studies on suicide history and clozapine treatment in veterans with psychotic disorders.

Publications

JCP
Antisuicidal Effects of Ketamine in Patients With Comorbid AUD
Original Research

Antisuicidal Effects of Ketamine in Patients With Comorbid AUD

April 24, 2024

Intranasal ketamine induced rapid antidepressant effects versus placebo but did not significantly change suicidal ideation scores in patients with alcohol use disorder and suicidal ideation with past attempt.
, , , et al
PCC
History of Suicide Attempt and Clozapine in Veterans With Schizophrenia
Original Research

History of Suicide Attempt and Clozapine in Veterans With Schizophrenia

November 1, 2022

This study evaluated whether a history of suicide attempt increases the odds of receiving clozapine treatment in veterans with schizophrenia or schizoaffective disorder.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe